Conventional vaccines consist of a very large number of virtually identical
molecules. While these have been extremely effective for prevention agains
t viral diseases, development of vaccines against rapidly changing pathogen
s such as human immunodeficiency virus (HIV) and hepatitis C virus has prov
ed to be more difficult. We propose a new approach to vaccination against t
hese rapidly mutating pathogens by the use of vaccines consisting of a set
of highly polymorphic recombinant molecules. (C) 2000 Harcourt Publishers L
td.